Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Oct 19;9(6):e00878. doi: 10.1002/prp2.878

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2021 The Authors. Pharmacology Research & Perspectives published by British Pharmacological Society and American Society for Pharmacology and Experimental Therapeutics and John Wiley & Sons Ltd.

This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.

PMC Copyright notice

Prevalence (%) of people receiving at least an antibiotic according to antibiotic classes by sex in 2000 (A), 2010 (B), 2018 (C) and 2019 (D). TET‐Tetraciclines (J01A); AMF‐Amfenicoles (J01B); PEN‐Penicillins (J01C); CEF‐Cefalosporins and carbapenems (J01D); SULF‐Sulfonamides and trimetoprim (J01E); MACR, LINC, STREPT‐ Macrolides, lincosamides e streptogrammines (J01F); AMM‐ amminoglucosides (J 01G); QUINO‐Quinolones (J01M); Combinations (J01R); OTHER including Glycopeptide, Imidazole derivates, Nitrofuran derivates (J01X)